TSP Capital Management Group, LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 150 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2014. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
TSP Capital Management Group, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$1,197,000
-22.7%
236,919
-66.1%
0.67%
-14.8%
Q3 2018$1,549,000
+131.5%
698,674
-47.4%
0.79%
+130.0%
Q2 2018$669,000
-80.0%
1,328,207
-7.6%
0.34%
-78.5%
Q1 2018$3,348,000
-7.8%
1,436,957
+12.4%
1.60%
-3.3%
Q4 2017$3,630,000
+9.5%
1,278,057
+10.3%
1.65%
+4.4%
Q3 2017$3,314,000
+18.1%
1,158,719
+2.0%
1.58%
+22.4%
Q2 2017$2,805,000
-26.9%
1,135,748
+6.8%
1.29%
-29.1%
Q1 2017$3,838,000
+22.3%
1,063,248
+20.0%
1.82%
+14.3%
Q4 2016$3,138,000
-4.5%
886,398
+9.0%
1.60%
-3.9%
Q3 2016$3,286,000
-8.5%
813,273
-0.6%
1.66%
-10.7%
Q2 2016$3,593,000
+11.1%
818,473
-4.4%
1.86%
+4.6%
Q1 2016$3,235,000
-75.2%
855,923
+2.9%
1.78%
-74.5%
Q4 2015$13,040,000
+50.0%
831,648
+0.8%
6.96%
+42.8%
Q3 2015$8,692,000
-57.6%
824,681
+1.5%
4.88%
-48.8%
Q2 2015$20,496,000
-10.6%
812,681
-1.2%
9.53%
-9.2%
Q1 2015$22,927,000
+48.7%
822,656
-2.6%
10.50%
+47.6%
Q4 2014$15,421,000
+41.8%
844,981
+0.7%
7.11%
+42.7%
Q3 2014$10,876,000
-17.9%
839,167
+3.4%
4.98%
-13.2%
Q2 2014$13,240,000
-7.6%
811,267
-0.0%
5.74%
-11.6%
Q1 2014$14,336,000
-29.2%
811,342
-3.0%
6.50%
-26.2%
Q4 2013$20,248,000
-34.8%
836,342
-4.5%
8.80%
-37.0%
Q3 2013$31,037,000
+82.2%
876,020
-19.7%
13.97%
+63.2%
Q2 2013$17,030,0001,090,9758.56%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2014
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders